Company News

Changsha, China — July 18, 2026 — Vivolight Medical officially launched the FastErazer 355 nm Cold Laser Atherectomy System during the 19th China Southern Endovascular Congress (SEC 2026), marking an important milestone in the development of China’s first independently developed 3...

Lima, Peru — On August 6, 2026, Vivolight Medical reached another important milestone in Latin America with the first clinical use of its Multimodal P80 OCT System in Peru at Hospital Nacional Guillermo Almenara Irigoyen.   The successful procedure marks a new step in the adoption of adva...

Melbourne, Australia — August 2026 — GPCE Melbourne 2026 successfully concluded at the Melbourne Convention and Exhibition Centre, bringing together general practitioners, nurses, practice managers, registrars, allied health professionals and industry partners from across Australia. &nb...

São Paulo, Brazil — July 30, 2026 — As SOLACI & SBHCI 2026 approaches its conclusion, Vivolight Medical is celebrating a successful first appearance at one of Latin America’s leading interventional cardiology congresses.   The debut represents an important milesto...

Shenzhen, China — June 2026 — Vivolight Medical is pleased to announce that FastErazer Three-Frequency Nd:YAG Laser Atherectomy System has received approval from China’s National Medical Products Administration, with registration number NMPA 20263011296.   Used together with d...

Vivolight Medical is pleased to introduce the new V900P/F Projection Vein Finder, the latest addition to its vein visualization product family.​   Building on the foundation of the V800P, the V900P/F brings a series of enhancements designed to support healthcare professionals during vascular ac...

Miami, USA — June 17, 2026 — WHX Miami 2026 has officially opened, bringing together healthcare professionals, distributors, and industry partners from across North America, Latin America, and beyond. As one of the leading healthcare exhibitions in the Americas, WHX Miami provides an imp...

Interventional cardiology has always been a discipline that thrives on exchange — across borders, across experience levels, and across clinical cultures. At CIT 2026, one of the most important interventional cardiology congresses in the Asia-Pacific region, this spirit of exchange was palpable...

Paris, France — May 19, 2026 — Vivolight Medical is pleased to announce its participation in EuroPCR 2026, taking place from May 19 to 22, 2026 at the Palais des Congrès de Paris. As one of the world’s leading gatherings for interventional cardiovascular field, EuroPCR bring...

Xi’an, China, Apr 29, 2026 — From April 27 to 29, the 2026 World Mayors Dialogue · Xi’an brought together mayors and distinguished guests from seven countries under the theme “Starting Point of the Silk Road, Harmony and Coexistence: Technology and Culture Empowering H...

  CIT 2026 once again brought together clinicians, researchers, and industry leaders in interventional cardiology — this time with a clear message: progress in this field is inherently global. As one of the most influential interventional cardiology platforms in the Asia-Pacific region,...

Dubai, Feb. 10, 2026 — WHX Dubai (formerly Arab Health) is in full swing this week at the Dubai Exhibition Centre (DEC), bringing together healthcare innovators, clinicians, and industry partners across the region and beyond. The show floor feels like a live feed of where healthcare is headin...